作者：
Brose,M.S. [1]
;
Nutting,C.M. [2]
;
Jarzab,B. [3]
;
Elisei,R. [4]
;
Siena,S. [5]
;
Bastholt,L. [6]
;
DeLaFouchardiere,C. [7]
;
Pacini,F. [8]
;
Paschke,R. [9]
;
Shong,Y.K. [10]
;
Sherman,S.I. [11]
;
Smit,J.W.A. [12]
;
Chung,J. [13]
;
Kappeler,C. [14]
;
Pe?a,C. [15]
;
Molnár,I. ;
Schlumberger,M.J.
作者单位：
Division of Endocrinology, Asan Medical Center, Seoul, South Korea
[1]
Radboud University Medical Center, Nijmegen, Netherlands
[2]
University of Texas MD Anderson Cancer Center, Houston, TX, United States
[3]
Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy
[4]
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
[5]
Unit of Endocrinology, University of Siena, Siena, Italy
[6]
Bayer HealthCare Pharmaceuticals, Whippany, NJ, United States
[7]
Department of Oncology, Odense University Hospital, Odense C, Denmark
[8]
Gustave Roussy and University Paris Sud, Villejuif, France
[9]
Department for Endocrinology and Nephrology, Leipzig University, Leipzig, Germany
[10]
Royal Marsden Hospital, London, United Kingdom
[11]
Bayer Pharma AG, Berlin, Germany
[12]
Department of Otorhinolaryngology, Head and Neck Surgery and Abramson Cancer Center, University of
[13]
Consortium Cancer Thyro?dien, Hospices Civils-Centre Anticancéreux, Lyon, France
[14]
Maria Sklodowska-Curie Memorial Cancer Centre, Institute of Oncology, Gliwice, Poland
[15]
发布时间
2014-10-14
换一批
